VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,841,000 | +36.7% | 178,470 | +78.5% | 0.30% | +67.6% |
| Q4 2017 | $2,078,000 | -99.9% | 100,000 | -31.2% | 0.18% | +95.7% |
| Q1 2017 | $1,604,005,000 | +89911.5% | 145,422 | +100.4% | 0.09% | +12.0% |
| Q3 2016 | $1,782,000 | -50.0% | 72,568 | -59.0% | 0.08% | -46.8% |
| Q2 2016 | $3,563,000 | -34.8% | 176,927 | +229.0% | 0.16% | -64.8% |
| Q4 2015 | $5,467,000 | +82.2% | 53,780 | +219.7% | 0.44% | +56.5% |
| Q3 2015 | $3,001,000 | +22.7% | 16,823 | +52.8% | 0.28% | -17.3% |
| Q2 2015 | $2,446,000 | +241.6% | 11,010 | +205.6% | 0.34% | +82.9% |
| Q1 2015 | $716,000 | – | 3,603 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |